Trevi Therapeutics
TRVI
#4980
Rank
$1.70 B
Marketcap
$13.26
Share price
-6.42%
Change (1 day)
394.78%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -$45.89 Million USD

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$47.94 Million USD a decrease over its 2023 earnings that were of -$28.71 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$45.89 Million-4.28%
2024 -$47.94 Million67%
2023 -$28.71 Million2.43%
2022 -$28.03 Million-14.45%
2021 -$32.76 Million1.36%
2020 -$32.32 Million23.64%
2019 -$26.14 Million27.54%
2018 -$20.5 Million